Events
SLAS 2012Date: February 4 - 8 2012 Location: San Diego, California, USA Attending: Ben Butterfield
|
6th Drug Discovery for Neurodegeneration conferenceDate: February 12-14 2012 Location: New York Attending: Katya Tsaioun, Ben Butterfield
|
SOT Annual Meeting & ToxExpoDate: March 11 - 15 2012 Location: San Francisco California Attending: Ben Butterfield, Harry Luithardt Presenting: Paul Walker, Katya Tsaioun, Chris Strock
|
Discovery Chemistry Congress, ADME & Predictive Toxicology, Flow ChemistryDate: March 13-14 2012 Location: Munich Attending: Bodo Spori
|
BIO - Europe Spring 2012Date: March 19-21 2012 Location: Amsterdam The Netherlands Attending: Bodo Spori
|
ADMET PK/TK and Drug MetabolismDate: March 22-23 2012 Location: USA, Charlotte, NC Attending: Katya Tsaioun
|
Biotrinity 2012Date: April 24 - 26 2012 Location: Newbury, UK Attending: Anthony Baxter
|
8th North American Drug Discovery WorkshopDate: April 12 2012 Location: USA, Cambridge, MA Attending: Katya Tsaioun, Chris Strock, Ben Butterfield, Paula Criss
|
DDI 2012Date: May 6 - 8 2012 Location: Germany Attending: Katya Tsaioun
|
2012 Bio International ConventionDate: June 18-21 2012 Location: Boston Convention & Exhibition Center, MA Attending: Katya Tsaioun, Anthony Baxter
|
ISSX 2012 18th North American Regional MeetingDate: October 14-18 2012 Location: USA, Dallas Texas, Attending: Ben Butterfield, Camille Berglund, Paula Criss
|
Genomic ADME - gADME™
Cyprotex's proprietary gADME™ system can alert you to genetic variations in drug metabolism, allowing for personalised doses, drug rescue and repositioning.
Learn more about gADME
In vitro Micronucleus Test
Cyprotex now offers the in vitro micronucleus test for genotoxicity assessment using an automated, high content screening method for improved detection and reliability.
Learn more about our in vitro MNT service
Drug Transporters
Cyprotex provides a full range of drug-transporter studies as recommended by the ITC white paper and EMA guidelines.
Learn more about transporters
By Dr. Katya Tsaioun, Chief Scientific Officer, Cyprotex
Wiley & Sons, March 2011
